Form 8-K - Current report:
SEC Accession No. 0000950170-25-074446
Filing Date
2025-05-19
Accepted
2025-05-19 16:41:17
Documents
10
Period of Report
2025-05-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K vera-20250514.htm   iXBRL 8-K 72422
  Complete submission text file 0000950170-25-074446.txt   182071

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vera-20250514.xsd EX-101.SCH 26983
12 EXTRACTED XBRL INSTANCE DOCUMENT vera-20250514_htm.xml XML 4723
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 25964597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)